Physician
Tri-County Hematology & Oncology Associates INC
Tri-County Hematology & Oncology Associates INC was paid $1.65M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 26% of everything it billed.
33Billing provider infoTRI-COUNTY HEMATOLOGY & ONCOLOGY ASSOCIATES INC
MASSILLON, OH 44646
MASSILLON, OH 44646
33aNPI1578600201assigned 01/31/2007
33bProvider typeHematology & Oncology Physician
28Total paid$1.65M
24GClaims117,099
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Ohio
Rank by total paid#3 of 27
Median peer was paid$13K
This provider vs. median122×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,857 | $283K | |
| 2019 | 20,126 | $270K | |
| 2020 | 18,373 | $231K | |
| 2021 | 18,893 | $281K | |
| 2022 | 15,795 | $271K | |
| 2023 | 13,325 | $190K | |
| 2024incomplete | 9,730 | $120K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 26% | 6,619 | 3,759 | $420K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 9,939 | 8,141 | $364K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 7,875 | 7,249 | $197K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.8% | 28,240 | 19,881 | $112K |
| 96367 | 5.4% | 4,173 | 2,500 | $88K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.9% | 4,671 | 2,973 | $81K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.6% | 2,073 | 1,388 | $59K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 3.4% | 781 | 456 | $56K |
| 80053 | Comprehensive metabolic panel | 3.0% | 10,174 | 8,034 | $50K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 2.8% | 161 | 114 | $46K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 18,568 | 13,541 | $29K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 4,726 | 3,055 | $29K |
28 more codes
| 82728 | 1.3% | 3,278 | $21K | |
| J0897 | Injection, denosumab, 1 mg | 1.2% | 28 | $20K |
| 83550 | <1% | 2,956 | $12K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 21 | $11K |
| 83615 | <1% | 3,708 | $10K | |
| 83540 | <1% | 3,129 | $10K | |
| 99205 | Prolong outpt/office vis | <1% | 81 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 323 | $4K |
| 96417 | <1% | 87 | $4K | |
| 99223 | Prolong inpt eval add15 m | <1% | 67 | $4K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 185 | $3K |
| 96401 | <1% | 113 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,672 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 142 | $2K |
| 82607 | <1% | 170 | $833.29 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,592 | $716.87 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $634.09 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 21 | $611.27 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 15 | $494.74 |
| 96415 | <1% | 16 | $459.77 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 26 | $349.47 |
| 82378 | <1% | 27 | $235.93 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 197 | $201.43 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 45 | $192.06 |
| 90686 | <1% | 13 | $138.91 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 140 | $91.20 |
| 83735 | <1% | 22 | $65.42 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 13 | $49.54 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAFIQUE, NOMAN (PRESIDENT)